Expression of CCL20 and Its Corresponding Receptor CCR6 Is Enhanced in Active Inflammatory Bowel Disease, and TLR3 Mediates CCL20 Expression in Colonic Epithelial Cells

BACKGROUND: The chemokine CCL20 and its receptor CCR6 are putative drug targets in inflammatory bowel disease, and CCL20 is a novel IBD predilection gene. Previous findings on the CCL20 response in these diseases are divergent. This study was undertaken to examine CCL20 and CCR6 during active and in...

Descripción completa

Detalles Bibliográficos
Autores principales: Skovdahl, Helene Kolstad, Granlund, Atle van Beelen, Østvik, Ann Elisabet, Bruland, Torunn, Bakke, Ingunn, Torp, Sverre Helge, Damås, Jan Kristian, Sandvik, Arne Kristian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4633243/
https://www.ncbi.nlm.nih.gov/pubmed/26536229
http://dx.doi.org/10.1371/journal.pone.0141710

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4633243/
https://www.ncbi.nlm.nih.gov/pubmed/26536229
http://dx.doi.org/10.1371/journal.pone.0141710

Ejemplares similares